Stabilized cyclopropane analogs of the splicing inhibitor FD-895.

J Med Chem

Department of Chemistry and Biochemistry, University of California San Diego, 9500 Gilman Drive, La Jolla, California 92093-0358, United States.

Published: September 2013

Targeting the spliceosome with small molecule inhibitors provides a new avenue to target cancer by intercepting alternate splicing pathways. Although our understanding of alternate mRNA splicing remains poorly understood, it provides an escape pathway for many cancers resistant to current therapeutics. These findings have encouraged recent academic and industrial efforts to develop natural product spliceosome inhibitors, including FD-895 (1a), pladienolide B (1b), and pladienolide D (1c), into next-generation anticancer drugs. The present study describes the application of semisynthesis and total synthesis to reveal key structure-activity relationships for the spliceosome inhibition by 1a. This information is applied to deliver new analogs with improved stability and potent activity at inhibiting splicing in patient derived cell lines.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809018PMC
http://dx.doi.org/10.1021/jm400861tDOI Listing

Publication Analysis

Top Keywords

stabilized cyclopropane
4
cyclopropane analogs
4
splicing
4
analogs splicing
4
splicing inhibitor
4
inhibitor fd-895
4
fd-895 targeting
4
targeting spliceosome
4
spliceosome small
4
small molecule
4

Similar Publications

Petal senescence represents a crucial phase in the developmental continuum of flowers, ensuing tissue differentiation and petal maturation, yet anteceding seed formation and development. Instigation of petal senescence entails myriad of changes at the cytological, physiological and molecular dimensions, mirroring the quintessential characteristics of cell death. In the current investigation biochemical and molecular intricacies were scrutinized across various developmental stages (bud to the senescent phase).

View Article and Find Full Text PDF

Unraveling the Cleavage Reaction of Hydroxylamines with Cyclopropenones Considering Biocompatibility.

J Am Chem Soc

December 2024

Key Laboratory of Biomedical Polymers of Ministry of Education, College of Chemistry and Molecular Sciences, The Institute of Molecular Medicine Medicine, Wuhan University People's Hospital, Hubei Province Key Laboratory of Allergy and Immunology, Wuhan University, Wuhan, Hubei 430072, China.

We develop a latent biocompatible cleavage reaction involving the hitherto unexplored interaction between hydroxylamines and cyclopropenones. Our study addresses the regioselectivity challenges commonly observed in asymmetric cyclopropenone transformations, substantiated by variations in substrate, Density Functional Theory calculations, and NMR analysis. This reaction is characterized by high efficiency, broad substrate scope, stability, latent biocompatibility, and mild reaction conditions.

View Article and Find Full Text PDF

Cyclopropanes, valuable C3 building blocks in organic synthesis, possess high strain energy and inherent stability. We present an efficient, environmentally benign 1,3-oxyheteroarylation of aryl cyclopropanes using azine -oxides as bifunctional reagents under visible light irradiation. This metal-free method yields β-pyridyl ketones under mild conditions.

View Article and Find Full Text PDF

Background: Ciprofol, a novel intravenous general anesthetic with a chemical structure similar to propofol, exhibits significantly enhanced potency. It offers a rapid onset, reduced incidence of injection pain, and has comparable effects on heart rate and blood pressure to propofol. However, clinical data on its use for anesthesia induction in cardiac surgery remain limited.

View Article and Find Full Text PDF
Article Synopsis
  • Tetrabutylammonium (TBA) salt of hexacyano-substituted cyclopropane dianion (Cp(CN) ) is developed using a simple two-step method and shows promise as a high-voltage n-type organic cathode for aqueous zinc-ion batteries (AZIBs).
  • Adding tetrabutylammonium triflate (TBAOTf) to the electrolyte helps reduce dissolution problems, improving the battery's cycling stability.
  • The Cp(CN) cathode achieves a high discharge voltage of 1.43 V and maintains 85% capacity after 1000 cycles, demonstrating its potential effectiveness in energy storage applications through a reversible two-electron redox process.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!